a bigger push to avoid ORAL diclofenac

You'll see a bigger push to avoid ORAL diclofenac.

Think of it as a "three-strikes" NSAID.

Strike one...it increases the risk of cardiac events as much as high-dose celecoxib (Celebrex)...or rofecoxib (Vioxx), which was withdrawn from the market because of its cardiovascular risk.

Get concise advice on drug therapy, plus unlimited access to CE

Pharmacist's Letter Canada includes:

  • 12 issues every year, with brief articles about new meds and hot topics
  • 300+ CE courses, including the popular CE-in-the-Letter
  • Quick reference drug comparison charts
  • Access to the entire archive

Already a subscriber? Log in

Volume pricing available. Get quote